Literature DB >> 27982595

When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?

Shipra Malhotra1, John Karanicolas1.   

Abstract

Traditional hit-to-lead optimization assumes that upon elaboration of chemical structure, the ligand retains its binding mode relative to the receptor. Here, we build a large-scale collection of related ligand pairs solved in complex with the same protein partner: we find that for 41 of 297 pairs (14%), the binding mode changes upon elaboration of the smaller ligand. While certain ligand physiochemical properties predispose changes in binding mode, particularly those properties that define fragments, simple structure-based modeling proves far more effective for identifying substitutions that alter the binding mode. Some ligand pairs change binding mode because the added substituent would irreconcilably conflict with the receptor in the original pose, whereas others change because the added substituent enables new, stronger interactions that are available only in a different pose. Scaffolds that can engage their target using alternate poses may enable productive structure-based optimization along multiple divergent pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27982595      PMCID: PMC5525026          DOI: 10.1021/acs.jmedchem.6b00725

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  49 in total

1.  A 'rule of three' for fragment-based lead discovery?

Authors:  Miles Congreve; Robin Carr; Chris Murray; Harren Jhoti
Journal:  Drug Discov Today       Date:  2003-10-01       Impact factor: 7.851

2.  The Uppsala Electron-Density Server.

Authors:  Gerard J Kleywegt; Mark R Harris; Jin Yu Zou; Thomas C Taylor; Anders Wählby; T Alwyn Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  The 'rule of three' for fragment-based drug discovery: where are we now?

Authors:  Harren Jhoti; Glyn Williams; David C Rees; Christopher W Murray
Journal:  Nat Rev Drug Discov       Date:  2013-07-12       Impact factor: 84.694

4.  Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.

Authors:  Alessio Innocenti; Daniela Vullo; Andrea Scozzafava; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2008-06-13       Impact factor: 3.641

5.  The additivity of substrate fragments in enzyme-ligand binding.

Authors:  T J Stout; C R Sage; R M Stroud
Journal:  Structure       Date:  1998-07-15       Impact factor: 5.006

6.  Conformer generation with OMEGA: learning from the data set and the analysis of failures.

Authors:  Paul C D Hawkins; Anthony Nicholls
Journal:  J Chem Inf Model       Date:  2012-11-12       Impact factor: 4.956

7.  Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).

Authors:  Alexandra Manos-Turvey; Esther M M Bulloch; Peter J Rutledge; Edward N Baker; J Shaun Lott; Richard J Payne
Journal:  ChemMedChem       Date:  2010-07-05       Impact factor: 3.466

8.  Isoquinoline-1,3,4-trione derivatives inactivate caspase-3 by generation of reactive oxygen species.

Authors:  Jun-Qing Du; Jian Wu; Hua-Jie Zhang; Ya-Hui Zhang; Bei-Ying Qiu; Fang Wu; Yi-Hua Chen; Jing-Ya Li; Fa-Jun Nan; Jian-Ping Ding; Jia Li
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

9.  Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.

Authors:  Paul A Brough; Xavier Barril; Jenifer Borgognoni; Patrick Chene; Nicholas G M Davies; Ben Davis; Martin J Drysdale; Brian Dymock; Suzanne A Eccles; Carlos Garcia-Echeverria; Christophe Fromont; Angela Hayes; Roderick E Hubbard; Allan M Jordan; Michael Rugaard Jensen; Andrew Massey; Angela Merrett; Antony Padfield; Rachel Parsons; Thomas Radimerski; Florence I Raynaud; Alan Robertson; Stephen D Roughley; Joseph Schoepfer; Heather Simmonite; Swee Y Sharp; Allan Surgenor; Melanie Valenti; Steven Walls; Paul Webb; Mike Wood; Paul Workman; Lisa Wright
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

10.  Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

Authors:  Douglas R Davies; Bjorn Mamat; Olafur T Magnusson; Jeff Christensen; Magnus H Haraldsson; Rama Mishra; Brian Pease; Erik Hansen; Jasbir Singh; David Zembower; Hidong Kim; Alex S Kiselyov; Alex B Burgin; Mark E Gurney; Lance J Stewart
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

View more
  10 in total

Review 1.  The versatility of boron in biological target engagement.

Authors:  Diego B Diaz; Andrei K Yudin
Journal:  Nat Chem       Date:  2017-07-25       Impact factor: 24.427

2.  Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue.

Authors:  Christine E Kaiser; Juan Pablo Rincon Pabon; Jittasak Khowsathit; M Paola Castaldi; Steven L Kazmirski; David D Weis; Andrew X Zhang; John Karanicolas
Journal:  ACS Synth Biol       Date:  2018-04-09       Impact factor: 5.110

3.  RosettaLigandEnsemble: A Small-Molecule Ensemble-Driven Docking Approach.

Authors:  Darwin Yu Fu; Jens Meiler
Journal:  ACS Omega       Date:  2018-04-02

4.  Isothermal Analysis of ThermoFluor Data can readily provide Quantitative Binding Affinities.

Authors:  Nan Bai; Heinrich Roder; Alex Dickson; John Karanicolas
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.996

5.  Discovery of a novel kinase hinge binder fragment by dynamic undocking.

Authors:  Moira Rachman; Dávid Bajusz; Anasztázia Hetényi; Andrea Scarpino; Balázs Merő; Attila Egyed; László Buday; Xavier Barril; György M Keserű
Journal:  RSC Med Chem       Date:  2020-03-04

6.  Leveraging nonstructural data to predict structures and affinities of protein-ligand complexes.

Authors:  Joseph M Paggi; Julia A Belk; Scott A Hollingsworth; Nicolas Villanueva; Alexander S Powers; Mary J Clark; Augustine G Chemparathy; Jonathan E Tynan; Thomas K Lau; Roger K Sunahara; Ron O Dror
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 11.205

7.  SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction.

Authors:  Harold Grosjean; Mehtap Işık; Anthony Aimon; David Mobley; John Chodera; Frank von Delft; Philip C Biggin
Journal:  J Comput Aided Mol Des       Date:  2022-04-15       Impact factor: 4.179

8.  What Makes GPCRs from Different Families Bind to the Same Ligand?

Authors:  Kwabena Owusu Dankwah; Jonathon E Mohl; Khodeza Begum; Ming-Ying Leung
Journal:  Biomolecules       Date:  2022-06-21

9.  Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.

Authors:  Federica Prati; Fabio Zuccotto; Daniel Fletcher; Maire A Convery; Raquel Fernandez-Menendez; Robert Bates; Lourdes Encinas; Jingkun Zeng; Chun-Wa Chung; Paco De Dios Anton; Alfonso Mendoza-Losana; Claire Mackenzie; Simon R Green; Margaret Huggett; David Barros; Paul G Wyatt; Peter C Ray
Journal:  ChemMedChem       Date:  2018-02-19       Impact factor: 3.466

10.  Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.

Authors:  Alexander Metz; Jan Wollenhaupt; Steffen Glöckner; Niki Messini; Simon Huber; Tatjana Barthel; Ahmed Merabet; Hans Dieter Gerber; Andreas Heine; Gerhard Klebe; Manfred S Weiss
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-08-23       Impact factor: 7.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.